← Back to Search

ABC123 Framework for Advanced Bladder Cancer

N/A
Recruiting
Led By Elizabeth Kessler
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >65 years old, or >60 with at least one deficit on a geriatric screen
English speaking only for the pilot portion
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This trial is testing a new way of treating older patients with advanced, incurable bladder cancer. The team will follow patients for six months to see if this new method is effective.

Who is the study for?
This trial is for people over 60 with advanced, incurable cancer who are seeing an oncologist for the first time. They must be able to sign a consent form, follow study procedures for 6 months, and speak English. It's not open to those who've had systemic therapy for another advanced cancer or have conditions that could interfere with the study.Check my eligibility
What is being tested?
The ABC123 framework is being tested in this pilot study. It integrates geriatric, oncology, and palliative medicine into care planning by an advanced practice provider alongside a medical oncologist. The goal is to see if it's feasible and matches patient-clinician goals.See study design
What are the potential side effects?
Since this trial tests a care planning framework rather than medication, traditional side effects like you'd expect from drugs aren't applicable here. However, there may be emotional or psychological impacts from discussing advanced cancer care plans.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 65, or over 60 with a health issue found in a senior's health check.
Select...
I speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility measured through recruitment
Feasibility measured through retention in follow up
Denture Retention

Trial Design

1Treatment groups
Experimental Treatment
Group I: Older patients with advanced cancerExperimental Treatment1 Intervention
Patients over 60 years old with advanced, incurable cancer.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,742 Previous Clinical Trials
2,152,689 Total Patients Enrolled
American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,385 Total Patients Enrolled
Elizabeth KesslerPrincipal InvestigatorUniversity of Colorado, Denver

Media Library

ABC123 Framework Clinical Trial Eligibility Overview. Trial Name: NCT05408507 — N/A
Cancer Research Study Groups: Older patients with advanced cancer
Cancer Clinical Trial 2023: ABC123 Framework Highlights & Side Effects. Trial Name: NCT05408507 — N/A
ABC123 Framework 2023 Treatment Timeline for Medical Study. Trial Name: NCT05408507 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would I be eligible to take part in this experiment?

"This clinical trial seeks to enrol 70 participants aged between 60 and 115, all of whom must have been diagnosed with urinary bladder cancer."

Answered by AI

What opportunities exist for patient participation in this experiment?

"According to clinicaltrials.gov, this research project is actively searching for participants and has been open since February 15th 2022. The trial was last updated on June 3rd 2022."

Answered by AI

What is the cap on enrolment for this clinical trial?

"Affirmative, the clinicaltrials.gov entry for this research suggests that recruitment is currently underway. The trial was initially posted on February 15th 2022 and most recently edited on June 3rd 2022; 70 participants are needed from a single medical centre."

Answered by AI

Does this research endeavor accept participants over the age of sixty?

"Consistent with the requirements for this research, participants must be at least 60 years of age and not exceed 115."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

I have auto immune disorder attacking my liver and am unable to receive the chemo that might save my life.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Care Planning Framework in Advanced Cancer (ABC123)
2022. "Care Planning Framework in Advanced Cancer (ABC123)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05408507.
All > Bladder Cancer
~29 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top